Malaria vaccines: the stage we are at
- 1 July 2007
- journal article
- Published by Springer Science and Business Media LLC in Nature Reviews Microbiology
- Vol. 5 (7), 487-489
- https://doi.org/10.1038/nrmicro1712
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Priming with an Adenovirus 35-Circumsporozoite Protein (CS) Vaccine followed by RTS,S/AS01B Boosting Significantly Improves Immunogenicity toPlasmodium falciparumCS Compared to That with Either Malaria Vaccine AloneInfection and Immunity, 2007
- Viral vectors for malaria vaccine developmentVaccine, 2007
- The Malaria Atlas Project: Developing Global Maps of Malaria RiskPLoS Medicine, 2006
- A Phase 2b Randomised Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in KenyaPLoS Clinical Trials, 2006
- Preclinical Evaluation of a Chimeric Malaria Vaccine Candidate in Montanide ISA 720®: Immunogenecity and Safety in Rhesus MacaquesHuman Vaccines, 2006
- Pre-erythrocytic malaria vaccines: towards greater efficacyNature Reviews Immunology, 2005
- Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trialThe Lancet, 2005
- Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus AnkaraProceedings of the National Academy of Sciences, 2005
- Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trialThe Lancet, 2004
- APlasmodium falciparumcandidate vaccine based on a six-antigen polyprotein encoded by recombinant poxvirusesProceedings of the National Academy of Sciences, 2003